We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFN
1076
DELISTED
Infinera Corporation Common Stock
INFN
$76K ﹤0.01%
+25,978
New +$97.6K
BGC icon
1077
BGC Group
BGC
$4.89B
$75K ﹤0.01%
+14,437
New +$74.9K
EGIO
1078
DELISTED
Edgio, Inc. Common Stock
EGIO
$72K ﹤0.01%
666
-8,957
-93% -$1.07M
CNSL
1079
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$70K ﹤0.01%
+14,296
New +$91.1K
MGNI icon
1080
Magnite
MGNI
$3.55B
$65K ﹤0.01%
+10,229
New +$62.8K
SRGA
1081
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$65K ﹤0.01%
512
+76
+17% +$10.9K
REI icon
1082
Ring Energy
REI
$339M
$63K ﹤0.01%
19,317
+1,263
+7% +$5.62K
MGI
1083
DELISTED
MoneyGram International, Inc. New
MGI
$51K ﹤0.01%
+20,751
New +$46.5K
OIBR.C
1084
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$51K ﹤0.01%
25,573
+25,173
+6,293% +$47.8K
SB icon
1085
Safe Bulkers
SB
$774M
$48K ﹤0.01%
+30,625
New +$47.6K
UMC icon
1086
United Microelectronic
UMC
$46.9B
$47K ﹤0.01%
+21,345
New +$43.6K
EXPR
1087
DELISTED
Express, Inc.
EXPR
$34K ﹤0.01%
626
-2,732
-81% -$187K
AUY
1088
DELISTED
Yamana Gold, Inc.
AUY
$31K ﹤0.01%
12,200
-210,122
-95% -$462K
PDS
1089
Precision Drilling
PDS
$974M
$25K ﹤0.01%
660
-2,953
-82% -$130K
CVIA
1090
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$23K ﹤0.01%
+11,830
New +$45.6K
DNR
1091
DELISTED
Denbury Resources, Inc.
DNR
$18K ﹤0.01%
+14,700
New +$26.7K
LLEX
1092
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$18K ﹤0.01%
29,261
– –
OTLKW
1093
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$14K ﹤0.01%
125,400
– –
AAT
1094
American Assets Trust
AAT
$1.4B
– –
-1,211
Closed -$56K
ABCB icon
1095
Ameris Bancorp
ABCB
$5.89B
– –
-64,927
Closed -$2.23M
ABEO icon
1096
Abeona Therapeutics
ABEO
$413M
– –
-1,919
Closed -$353K
ABEV icon
1097
Ambev
ABEV
$46.4B
– –
-4,560,794
Closed -$19.6M
ABR icon
1098
Arbor Realty Trust
ABR
$998M
– –
-67,022
Closed -$869K
AC
1099
DELISTED
Associated Capital Group
AC
– –
-1,331
Closed -$52K
ACA icon
1100
Arcosa
ACA
$7.11B
– –
-3,324
Closed -$102K
42 43
44
45 46

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.